This phase II/III trial studies how well pegylated liposomal doxorubicin hydrochloride with atezolizumab and/or bevacizumab work in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has come back (recurrent). Chemotherapy drugs, such ...
- Carcinoma
- Adenocarcinoma
- Ovarian Neoplasms
- Carcinoma, Ovarian Epithelial
- Fallopian Tube Neoplasms
- Cystadenocarcinoma, Serous
- Carcinoma, Endometrioid
- Adenocarcinoma, Clear Cell
Age: 18 years - 66+
Gender: Female